血管平滑肌脂肪瘤细针穿刺诊断的挑战:33例研究
该研究回顾性分析了2003至2015年间经手术病理确认的33例血管平滑肌脂肪瘤(AML)细针穿刺(FNA)病例,评估诊断准确性、挑战及细胞学特征。结果显示FNA诊断AML具挑战性,尤其以上皮样细胞为主或肾外部位时,免疫染色有助于提高诊断准确性。
要点
- 上皮样细胞为主的AML诊断困难,3例转移性AML及2例误诊病例均见此特征。
- 肾外部位AML(肝、肺、腹壁)易误诊,3例误诊中2例为肾细胞癌。
- 免疫染色在11例FNA中实施,9例有助于诊断。
核心结论
- FNA诊断AML具挑战性,尤其以上皮样成分为主和/或肾外部位时,免疫染色对提高诊断准确性重要。
研究设计与样本
- 回顾性研究,检索2003至2015年病理数据库,纳入33例经手术病理确认的AML FNA病例(来自31例患者)。
主要发现
- 最终手术病理诊断:30例原发AML(肾28例,肝2例),3例转移(肝、肺、腹壁各1例)。
- FNA诊断:一致/倾向AML 16例,描述性12例,无法诊断2例,错误3例(2例肾细胞癌,1例多形性恶性肿瘤)。
- 细胞学上以梭形细胞为主最常见(19例),上皮样细胞为主6例,所有3例转移性AML及3例错误中的2例均见上皮样细胞为主。
- 免疫染色在11例FNA中实施,9例有助于诊断。
临床怎么用
- 对上皮样细胞为主或肾外部位的AML,FNA诊断需警惕误诊,应结合免疫染色辅助诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Angiomyolipoma (AML), typically composed of smooth muscle, vessels, and fat, is generally a benign tumor in the kidneys. However, it occasionally occurs in extrarenal sites and behaves like a malignant tumor. AML is uncommonly encountered in fine-needle aspiration (FNA) samples and can cause diagnostic difficulty. METHODS: We searched our pathology database for FNA cases diagnosed between 2003 and 2015 that were subsequently confirmed to be AML in the same lesion by surgical pathologic evaluation. The diagnostic performance, challenges, and cytologic features were retrospectively reviewed. RESULTS: In total, 33 FNA cases from 31 patients were identified. The final surgical pathologic diagnoses included 30 primary AMLs (28 in kidneys and 2 in liver) and 3 were metastases (in liver, lung, and abdominal wall, respectively). Aspiration sites included kidney/retroperitoneum (n = 28), abdominal wall (n = 1), lung (n = 1), and liver (n = 3). The FNA diagnoses were consistent with/favor AML (n = 16), descriptive (n = 12), nondiagnostic (n = 2), and erroneous (n = 3). Of the 3 erroneous cases, 2 were diagnosed as renal cell carcinoma, and 1 was diagnosed as a pleomorphic malignant neoplasm. Cytologically, cases with predominantly spindle cells were the most commonly encountered (n = 19). Cases with predominantly epithelioid cells (n = 6) can pose a diagnostic difficulty and were observed in all 3 metastatic AMLs and in 2 of the 3 erroneous cases. Immunostains were performed on 11 FNAs and helped the diagnosis in 9 cases. CONCLUSIONS: FNA diagnosis of AML may be challenging, especially in cases with a predominantly epithelioid component and/or an extrarenal location. Immunostaining is important to improve diagnostic accuracy of this rare entity. Cancer Cytopathol 2017;125:257-266. © 2016 American Cancer Society.
引用
- Zhou H, Guo M, Gong Y, et al. Challenge of FNA diagnosis of angiomyolipoma: A study of 33 cases. Cancer Cytopathol. 2017. PMID: 28152270. doi:10.1002/cncy.21824
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。